{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T17:11:39Z","timestamp":1700413899715},"reference-count":55,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2006,8,22]],"date-time":"2006-08-22T00:00:00Z","timestamp":1156204800000},"content-version":"vor","delay-in-days":4496,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Surgical Oncology"],"published-print":{"date-parts":[[1994,5]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>In all but one of seven recent epidemiologic case\u2010control and cohort studies directly examining the association between aspirin and colorectal cancer and polyps, regular aspirin use reduced the risk of these diseases by about half. Although these studies show a biologically plausible relationship between aspirin and colorectal cancer, information regarding dose and duration and risk change after discontinuation of aspirin is limited and contradictory. Additionally, selection bias, recall bias, and confounding cannot be completed discounted. The one randomized trial of aspirin and placebo showed that aspirin at a dose adequate for preventing myocardial infarction (325 mg every other day) did not reduce colorectal cancer incidence during five years of randomized treatment and follow\u2010up. Further studies need to determine the biologic effects of aspirin, the minimum dose required, and whether other factors, such as age, illnesses, and reasons for aspirin use, modify or confound colorectal cancer development. \u00a9 1994 Wiley\u2010Liss, Inc.<\/jats:p>","DOI":"10.1002\/ssu.2980100303","type":"journal-article","created":{"date-parts":[[2007,2,22]],"date-time":"2007-02-22T09:10:26Z","timestamp":1172135426000},"page":"158-164","source":"Crossref","is-referenced-by-count":18,"title":["Aspirin and the prevention of colorectal cancer: A review of the evidence"],"prefix":"10.1002","volume":"10","author":[{"given":"Annlia","family":"Paganini\u2010Hill","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,8,22]]},"reference":[{"key":"e_1_2_1_2_2","first-page":"250","volume-title":"The Healing Herbs","author":"Castleman M","year":"1991"},{"key":"e_1_2_1_3_2","volume-title":"Cancer Facts and Figures\u20141993","author":"American Cancer Society","year":"1993"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1038\/338389a0"},{"key":"e_1_2_1_5_2","first-page":"4399","article-title":"Colorectal cancer risk, chronic illnesses, operations and medications: Case control results from the Melbourne Colorectal Cancer Study","volume":"48","author":"Kune GA","year":"1988","journal-title":"Cancer Res"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/83.5.355"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199112053252301"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19930815)72:4<1171::AID-CNCR2820720407>3.0.CO;2-D"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/85.11.912"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.307.6899.285"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.299.6710.1247"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/83.16.1182-a"},{"key":"e_1_2_1_13_2","first-page":"1290","article-title":"Aspirin use and reduced risk of fatal colon cancer (letter)","volume":"326","author":"Paganini\u2010Hill A","year":"1992","journal-title":"N Engl J Med"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1002\/jso.2930240119"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9610(89)90442-X"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(91)90519-Q"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-115-12-952"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199305063281805"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/85.15.1220"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/4.10.1225"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/13.4.541"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1002\/path.1711560411"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.7291992"},{"key":"e_1_2_1_24_2","first-page":"5340","article-title":"Dose\u2010related inhibition of colon carcinogenesis by dietary piroxicam, a nonsteroidal an\u2010tiinflammatory drug, during different stages of rat colon tumor development","volume":"47","author":"Reddy BS","year":"1987","journal-title":"Cancer Res"},{"key":"e_1_2_1_25_2","first-page":"1954","article-title":"Inhibition of development of methylnitrosourea\u2010induced rat colon tumors by indomethacin treatment","volume":"41","author":"Narisawa T","year":"1981","journal-title":"Cancer Res"},{"key":"e_1_2_1_26_2","first-page":"377","article-title":"Inhibition of development of methylnitrosourea\u2010induced rat colonic tumors by peroral administration of indomethacin","volume":"73","author":"Narisawa T","year":"1982","journal-title":"Gann"},{"key":"e_1_2_1_27_2","first-page":"2562","article-title":"Chemoprevention of colon carcinogenesis by concurrent administration of piroxicam, a nonsteroidal antiinflammatory drug with D, L\u2010\u03b1\u2010di\u2010fluromethylornithine, an ornithine decarboxylase inhibitor, in diet","volume":"50","author":"Reddy BS","year":"1990","journal-title":"Cancer Res"},{"key":"e_1_2_1_28_2","first-page":"4528","article-title":"Chemoprevention of colon carcinogenesis by dietary administration of piroxicam, \u03b1\u2010difluoromethylornithine, 16\u03b1\u2010fluoro\u20105\u2010androsten\u201017\u2010one, and ellagic acid individually and in combination","volume":"51","author":"Rao CV","year":"1991","journal-title":"Cancer Res"},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/13.6.1019"},{"key":"e_1_2_1_30_2","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/14.8.1493"},{"key":"e_1_2_1_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-6980(74)80055-9"},{"key":"e_1_2_1_32_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1977.132"},{"key":"e_1_2_1_33_2","doi-asserted-by":"publisher","DOI":"10.1159\/000200492"},{"key":"e_1_2_1_34_2","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.240501330"},{"key":"e_1_2_1_35_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI111093"},{"key":"e_1_2_1_36_2","first-page":"308","article-title":"Inhibition by prosta\u2010glandin synthesis inhibitors of the induction of epidermal ornithine decarboxylase activity, the accumulation of prosta\u2010glandins, and tumor promotion caused by 12\u2010O\u2010tetradecanoyl\u2010phorbol\u201013 acetate","volume":"40","author":"Verma AK","year":"1980","journal-title":"Cancer Res"},{"key":"e_1_2_1_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/0090-6980(80)90153-7"},{"key":"e_1_2_1_38_2","first-page":"5575","article-title":"Aspirin and the potential role of prostaglandins in colon cancer","volume":"52","author":"Marnett LJ","year":"1992","journal-title":"Cancer Res"},{"key":"e_1_2_1_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(83)90157-5"},{"key":"e_1_2_1_40_2","first-page":"446","article-title":"Antiprolif\u2010erative activity of anti\u2010inflammatory drugs in two mammalian cell culture lines","volume":"202","author":"Hial V","year":"1977","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_1_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(79)90112-6"},{"key":"e_1_2_1_42_2","doi-asserted-by":"publisher","DOI":"10.1038\/263777a0"},{"key":"e_1_2_1_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(85)90209-4"},{"key":"e_1_2_1_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/0192-0561(83)90066-8"},{"key":"e_1_2_1_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(84)80086-8"},{"key":"e_1_2_1_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793(77)80704-7"},{"key":"e_1_2_1_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/0009-2797(91)90108-J"},{"key":"e_1_2_1_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(93)90667-2"},{"key":"e_1_2_1_49_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-198223010-00004"},{"key":"e_1_2_1_50_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1990.tb03841.x"},{"key":"e_1_2_1_51_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198905113201903"},{"key":"e_1_2_1_52_2","first-page":"1045","article-title":"Analgesics, cigarette smoking, and other risk factors for cancer of the renal pelvis and ureter","volume":"49","author":"Ross RK","year":"1989","journal-title":"Cancer Res"},{"key":"e_1_2_1_53_2","doi-asserted-by":"publisher","DOI":"10.1016\/0895-4356(92)90118-7"},{"key":"e_1_2_1_54_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/85.4.307"},{"key":"e_1_2_1_55_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198801283180431"},{"key":"e_1_2_1_56_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.296.6618.313"}],"container-title":["Seminars in Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fssu.2980100303","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ssu.2980100303","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,24]],"date-time":"2023-10-24T18:19:29Z","timestamp":1698171569000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ssu.2980100303"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1994,5]]},"references-count":55,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1994,5]]}},"alternative-id":["10.1002\/ssu.2980100303"],"URL":"https:\/\/doi.org\/10.1002\/ssu.2980100303","archive":["Portico"],"relation":{},"ISSN":["8756-0437","1098-2388"],"issn-type":[{"value":"8756-0437","type":"print"},{"value":"1098-2388","type":"electronic"}],"subject":[],"published":{"date-parts":[[1994,5]]}}}